Ibrutinib is a BTK inhibitor. It’s used for treating MCL, CLL, and Waldenström’s macroglobulinemia. You can find it in 140 mg capsules or tablets.
The usual dosage is between 420 to 560 mg, taken just once a day. The tablets come in bottles, each with 90 of them. The main ingredient in the drug is good at stopping cancer cells from growing by blocking a protein called BTK.
It’s a prescription drug meant to deal with some kinds of lymphoma and leukemia. The treatment’s purpose is to help people live longer and feel better if they have those blood cancer types.
